A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects

NCT00296504 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

753

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG: fosamprenavir (GW433908)
DRUG: ritonavir

Sponsor

ViiV Healthcare

Collaborators

[object Object]